Therapeutic Goods (Restricted Representations - Panadol Rapid) Permission 2020

I, Leanne McCauley, as delegate of the Secretary of the Department of Health, make the following permission.

Dated 19 June 2020

Leanne McCauley
Director, Advertising Education and Assurance Section
Regulatory Compliance Branch
Health Products Regulation Group
Department of Health

Contents

1 Name

This instrument is the Therapeutic Goods (Restricted Representations—Panadol Rapid) Permission 2020.

2 Commencement

1. Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

2. Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority

This instrument is made under section 42DK of the Therapeutic Goods Act 1989.

4 Definitions

Note: A number of expressions used in this instrument are defined in section 3 of the Act, including the following:
(a) advertise;
(b) label;
(c) Register; and
(d) registration number.

In this instrument:

Act means the Therapeutic Goods Act 1989.

Panadol Rapid means the registered medicine, Panadol Rapid paracetamol 500mg tablet blister pack (reformulation), registration number 332528.

registered medicine means a medicine that is included in the part of the Register for goods known as registered goods.

restricted representation means a representation referred to in section 42DD of the Act

5 Permission - restricted representation

For subsection 42DK(1) of the Act, in relation to each item mentioned in the table in Schedule 1, the restricted representations specified in column 2 are permitted to be used in the advertisements specified in column 3, about the therapeutic goods specified in column 4, subject to the conditions (if any) specified in column 5.

Schedule 1 - Permission: restricted representation

Note: See section 5.